baber/WOPTO huggingface dataset:
Patent AT-E312461-T1 (AT)
Inventor: LUDWIG REINER
IPC: H04L1/16
Filed: 1999-07-01
Granted: 2005-12-15
Abstract: In the present invention, the implementation of a protocol that embeds packets is made sensitive to the type of data being embedded, so that adjustable parameters can be set automatically at the layer providing the parameters being adjusted in accordance with the packets being embedded. Thus it is taken into account that the data in packets being received from a higher layer in order to be encapsulated or segmented and sent further (either directly into the link or on to lower layer), may be classified into different categories with respect to the adjustable parameters, where the parameters can automatically be adjusted for an individual packet in accordance with the category into which is classified. <IMAGE>
Patent AT-E297908-T1 (AT)
Inventor: MCCLURE KIM FRANCIS
IPC: A61K31/5355
Filed: 1999-08-05
Granted: 2005-07-15
Abstract: A compound of the formula wherein R<SUP>1</SUP>, R<SUP>2 </SUP>R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6 </SUP>and Q are as defined above, useful in the treatment of arthritis, cancer, and other diseases involving the dysregulated production/release of reprolysins such as TNF and other diseases characterized by matrix metalloproteinase activity. In addition, the compounds of the present invention may be used in combination therapy with standard non-steroidal anti-inflammatory drugs (NSAID's), COX-2 inhibitors and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinum, etoposide, taxol, taxotere and other alkaloids, such as vincristine, in the treatment of cancer.
Patent AT-E248788-T1 (AT)
Inventor: ORNSTEIN IAN NEAL
IPC: B05D7/00
Filed: 1999-07-21
Granted: 2003-09-15
Abstract: Calcitic and/or siliceous architectural and construction materials are provided with increased resistance to damage from water, oil, grease and weather by a process which comprises treating said materials with an aqueous composition containing:(A) from about 0.1 to 4% by weight on a 100% solids basis of an aqueous solution or self-dispersed emulsion or dispersion of a copolymer which is a reaction product of monomers containing fluorinated groups, cationic groups and nonionic groups,(B) an effective amount of a penetration assistant, and(C) water to make up 100%.
Patent AT-E243616-T1 (AT)
Inventor: HENNINGSEN HENNING
IPC: B29C67/00
Filed: 1999-10-12
Granted: 2003-07-15
Abstract: The invention relates to a rapid prototyping apparatus for the manufacturing of three dimensional objects by additive treatment of cross sections comprising a wholly or partially light-sensitive material, said apparatus comprising at least one light source for illumination of a cross section of the light-sensitive material by at least one spatial light modulator of individually controllable light modulators, wherein at least one light source is optically coupled with a plurality of light guides arranged with respect to the spatial light modulator arrangement in such a manner that each light guide illuminates a sub-area of the cross section. According to the invention, it is possible to obtain a significant simplification of an RP design system, just as the apparatuses designed are essentially capable of creating prototypes of any size, according to the invention.
Patent AT-E246281-T1 (AT)
Inventor: KAY JOHN GRANVILLE
IPC: E04F15/10
Filed: 1999-10-11
Granted: 2003-08-15
Abstract: A floor covering material (1) comprising a PVC layer (3) having embedded aggregate (6) for providing surface roughness. The material incorporates a barrier layer (4) of polymeric material other than PVC fused into the upper surface of the PVC layer (3), the aggregate (6) being exposed at the surface of the barrier layer (4).
Patent AT-E272651-T1 (AT)
Inventor: ANKERSEN MICHAEL
IPC: A61K38/00
Filed: 1999-11-03
Granted: 2004-08-15
Abstract: This invention relates to novel compounds, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone.
Patent DE-01952502-T1 (DE)
Title: Kodeleistungsmessung für dynamische kanalzuwendung
Inventor: PAN JUNG-LIN
IPC: H04J13/00
Filed: 2001-07-06
Abstract: Verfahren zum Zuweisen von Ressourceneinheiten in einer Zelle eines drahtlosen Zeitduplex- (TDD) Kommunikationssystems, wobei jede Ressourceneinheit einem Zeitschlitz und einem Code zugeordnet wird, wobei das Verfahren die Schritte aufweist:  Messen eines Code-Interferenzpegels für ausgewählte der Ressourceneinheiten der Zelle während des Zeitschlitzes dieser Einheit unter Verwendung des Codes dieser Einheit und Bestimmen, ob diese Einheit einen zulässigen Code-Interferenzpegel aufweist, basierend auf einem Vergleich zwischen dem gemessenen Code-Interferenzpegel dieser Einheit und einem Schwellenwert; und  Zuweisen von Ressourceneinheiten unter den ausgewählten Ressourceneinheiten, die einen zulässigen Code-Interferenzpegel aufweisen, zu Kommunikationen.
Patent DE-213676-T1 (DE)
IPC: A61K38/04
Filed: 1986-08-22
Abstract: Pharmaceutical compositions containing ACTH(1-24) are effective in the treatment of shock conditions and of respiratory and cardiocirculatory insufficiency. The compositions of the invention may be administered by parenteral or inhalatory route at a dosage ranging from 1 to 10 mg of active principle.
Patent DE-242263-T1 (DE)
IPC: F16G5/16
Filed: 1987-04-03
Abstract: An endless power transmission V belt is provided including a longitudinal reinforcement member formed by at least one member resistant to a tensile force such as a cable, made from a material chosen from metal, glass fibers or the like having a high tensile strength, transverse elements made from metal or another material having compression strength and an elastomer mass which integrally assembles the transverse elements together and with the longitudinal reinforcement member. The latter is blocked upright at least one transverse element by a nipping effect between said element or a part thereof and a piece cooperating therewith, such as a bar or the like, which is firmly secured thereto by appropriate means such as spot welding on the contact zones between said element and said piece, exclusively.
Patent ES-2214166-T1 (ES)
Title: Polipeptidos has-ilados, especialmente, eriptropoyetina has-ilada.
Inventor: CONRADT HARALD S
IPC: A61K47/48
Filed: 2002-09-11
Abstract: Un conjugado hidroxialquilalmidón (HAS)-eri-tropoyetina (EPO) (HAS-EPO), que comprende una o más moléculas de HAS, en donde cada HAS está conjugado con la EPO vía a) un resto de carbohidrato; o b) un tioéter.
Patent ES-2098203-T1 (ES)
Title: Contenedor para productos pre-empaquetados.
Inventor: RESTA ALESSANDRO
IPC: B65D5/54
Filed: 1995-07-05
Abstract: UNA CAJA, DE UN TIPO QUE COMPRENDE UN UNICO ELEMENTO CORTADO A TROQUEL (1) DOBLADA POR UNA PLURALIDAD DE LINEAS DE DOBLEZ, Y PROVISTA CON UNA LENGUETA (5) PEGADA AL PRIMER LADO (6) PARA FORMAR EL CUERPO DE UNA CAJA Y UNA PLURALIDAD DE SOLAPAS (8) QUE PUEDEN CERRARSE DESPUES DE HABER AÑADIDO LOS CONTENIDOS, QUE TIENE UN SEGUNDO LADO (2) PROVISTO CON LINEAS DE CORTE PRETROQUELADAS (7) PARA PERMITIR UNA SEPARACION PARCIAL DEL MENCIONADO LADO (2) DESDE LOS LADOS ADYACENTES Y LA CONSECUENTE APERTURA DE LA CAJA EN EL AREA DE DICHO LADO (2).
Patent CY-1108895-T1 (CY)
Inventor: STEINER MITCHELL S
IPC: A61P43/00
Filed: 2009-03-23
Abstract: This invention relates to the use of a selective estrogen receptor modulator (SERM) for the preparation of a pharmaceutical composition for treating androgen-deprivation induced loss of bone mineral density (BMD) or androgen-deprivation induced bone fractures in a male subject having prostate cancer.
Patent CY-1111682-T1 (CY)
Inventor: WATERHOUSE PETER MICHAEL
IPC: C12N15/82
Filed: 2011-07-05
Abstract: Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells, particularly plant cells, by introducing a chimeric RNA molecule comprising at least one RNA region with a nucleotide sequence comprising 
i. a sense nucleotide sequence of at least 15 consecutive nucleotides having 100% sequence identity with at least part of the nucleotide sequence of the nucleic acid of interest; and 
ii. an antisense nucleotide sequence including at least 15 consecutive nucleotides, having about 100% sequence identity with the complement of said at least 15 consecutive nucleotides of said sense nucleotide sequence; 
wherein said RNA region is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence such that said at least 15 consecutive nucleotides of the sense sequence basepair with said at least 15 consecutive nucleotides of the antisense sequence, wherein said nucleic acid of interest is a gene integrated into the genome of said eukaryotic cell, wherein said RNA molecule is produced by transcription of a chimeric gene.
Patent CY-1112329-T1 (CY)
Inventor: FRANANO NICHOLAS F
IPC: A61K38/48
Filed: 2011-09-08
Abstract: The invention provides methods to treating an obstructed biological conduit, that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue. Particular methods include delivery of an enzyme or a mixture of several enzymes to the area or region of obstruction wherein the enzyme(s) have the capability to degrade extracellular matrix components within the obstruction thereby restoring the normal flow of transported fluid through the conduit. The invention also includes preventively dilating a section of conduit to minimize the risk of obstruction formation.
Patent CY-1115436-T1 (CY)
Title: Αναστολεις της κινασης p70 s6
Inventor: DALLY ROBERT DEAN
IPC: A61P35/00
Filed: 2014-08-06
Abstract: Η παρούσα εφεύρεση παρέχει αναστολείς της κινάσης p70 S6 του παρακάτω τύπου, καθώς και φαρμακευτικές τυποποιήσεις που τις περιλαμβάνουν, και μεθόδους χρήσης αυτών.
Patent CY-1119896-T1 (CY)
Title: Μεθοδοι για αγωγη toy hcv
Inventor: RAY ADRIAN S
IPC: A61P31/14
Filed: 2018-02-06
Abstract: Αυτή η εφεύρεση σχετίζεται με συνδυασμούς θεραπευτικών μορίων χρήσιμων για αγωγή της λοίμωξης από ιό ηπατίτιδας C. Η παρούσα εφεύρεση σχετίζεται με μεθόδους, χρήσεις, σχήματα χορήγησης δοσολόγησης, και συνθέσεις.
Patent CY-1124860-T1 (CY)
Title: Μεθοδος παραγωγης κλινκερ με χαμηλες εκπομπες ανθρακα
Inventor: JESUS DE SEQUEIRA SERRA NUNES ANGELA MARIA
IPC: C04B7/19
Filed: 2020-03-10
Abstract: Μέθοδος παραγωγής κλίνκερ με χαμηλές εκπομπές άνθρακα, με χαμηλή κατανάλωση ενέργειας, η οποία περιλαμβάνει τα ακόλουθα στάδια: προπύρωση του ασβεστόλιθου που υπάρχει στην πρώτη ύλη, στη μονάδα προπύρωσης και στον κυκλωνικό πύργο˙ έναρξη της διαδικασίας παραγωγής κλίνκερ με την είσοδο πρώτης ύλης μετά από προπύρωση, σε θερμοκρασία μεγαλύτερη από 1400 °C και με περιεκτικότητα σε C3S άνω του 60%˙ ψύξη του υλικού, και τέλος εισαγωγή 5 έως 30% πυριτικών-αργιλικών υλικών σε σχέση με τη μάζα του υλικού που υφίσταται επεξεργασία στο στάδιο ψύξης, στην κεφαλή του ψυκτήρα.
Patent CY-1122929-T1 (CY)
Title: Πρωτεϊνες συγχωνευσης
Inventor: BALDWIN DAVID BRUCE
IPC: C07K14/62
Filed: 2020-03-16
Abstract: Η παρούσα εφεύρεση αναφέρεται σε πρωτεΐνες συγχώνευσης που περιλαμβάνουν έναν αγωνιστή υποδοχέα ινσουλίνης συγχωνευμένο σε μία ανθρώπινη περιοχή IgG Fc μέσω της χρήσης ενός πεπτιδικού συνδετήρα, και στη χρήση αυτών των πρωτεϊνών συγχώνευσης στην αγωγή του διαβήτη. Η πρωτεΐνη συγχώνευσης της παρούσας εφεύρεσης έχει προφίλ παρατεταμένου χρόνου δράσης και είναι χρήσιμη για την παροχή ελέγχου βασικής γλυκόζης επί παρατεταμένη χρονική περίοδο.
Patent GR-930300042-T1 (GR)
Title: Method for guiding a digging tool during the excavation of a trench wall, and digging tool to be used in the method.
Inventor: DUPEUBLE PAUL
IPC: E02F3/20
Filed: 1993-06-21
Abstract: The invention relates to a method for guiding the digging tool used to dig the trenches necessary for forming, by successive or alternate panels, a wall cast in the ground, characterised in that : 
 
  a) a digging tool (4) equipped with a first guiding means (5) is provided, 
  b) a second guiding means (3) is arranged at the end of a previously dug trench, which extends substantially over the whole depth of this trench; then 
  c) the guiding means are engaged after the panel (1) has been formed in the previously dug trench; and 
  d) the digging tool is controlled so as to create a force which tends to keep the guiding means mutually engaged while the next trench is being dug. 
 
<??>Use in the civil engineering field 
<IMAGE>
Patent HR-P20110806-T1 (HR)
Inventor: WACKER DEAN A
IPC: C07D401/12
Filed: 2011-11-02
Abstract: Spoj izabran između spojeva Formule I i Formule IA: i njegovi enantiomeri, diastereomeri, solvati i farmaceutski prihvatljive soli, s prstenom A i prstenom B, gdje: prsten A je po izboru supstituiran jednim ili više R koji su prikazani kao R20 i R21;G je CH ili N; Q je C ili N; X je CH ili N, uz uvjet da oba Q i X nisu N; Y je CH2, N(R3), C(=O), O, OCR9R9, S, S(=O) ili S(O)2;n1 je 0-2; n2 je 0-2; n3 je 1-2; R1 je 6-eročlani monociklički aril, 5-eročlani monociklički heteroaril ili 6-eročlani monociklički heteroaril, od kojih svaki y može biti po izboru supstituiran jednim ili više članova izabranih između R1a, R1b, R1c, R1d i R1e;R1a, R1b, R1c, R1d i R1e su svaki nezavisno izabrani iz grupe koja obuhvaća vodik, alkil, alkenil, alkinil, cikloalkil, aril, heterociklil, halogen, -NH2, -CN, -NO2, -C(=O)OH, -C(=O)OR10, -OCF3, -OR11, -OH, -SH, -SR11,-S(O)3H, -P(O)3H2, -C(=O)NR9R9, -NR12R12, -S(O)2NR9R9, -NR9S(O)2CF3, -C(=O)NR9S(O)2R9, -S(O)2NR9C(=O)OR9, -S(O)2NR9C(=O)NR9R9, -C(=O)NR9S(O)2CF3, -C(=O)R11, -NR9C(=O)H,-NR9C(=O)R10, -OC(=O)R10, -OC(=O)NR9R9, -C(=NR14)NR9R9, -NHC(=NR14)NR14R14, -S(=O)R11, -S(O)2R11, -NR9C(=O)OR8 i -NR9S(O2)R8, gdje: (a) alkenil, alkinil, cikloalkil, aril i heterociklil može svaki biti po izboru supstituiran jednim ili više R6; i (b) alkil može po izboru biti supstituiran jednim ili više R7;R2 je cikloalkil, aril, heteroaril, heterociklil, -S(O)2R5, -C(=O)NR3R5, -C(=O)R5 ili -C(=O)OR5, gdje cikloalkil, aril, heteroaril i heterociklil može svaki biti po izboru supstituiran jednim ili više R6;R3 je vodik, alkil, alkoksi, cikloalkil, aril, arilalkil, heteroaril, heteroarilalkil, heterociklil ili heterociklilalkil; R5 je alkil, alkenil, aril, cikloalkil, heteroaril ili heterociklil, od kojih svaki može po izboru biti supstituiran jednim ili više R6;R6, svaki put kada je prisutan, je nezavisno izabran između alkila, halogenalkila, arila, alkenila, alkinila, cikloalkila, cikloalkilalkila, heteroarila, heteroarilalkila, heterociklila, heterociklilalkila, halogena, -NH2, -CN, -NO2, -C(=O)OH, -C(=O)OR10, -OCF3, -OR10, -OH, -SH, -SR10, -S(O)3H, -P(O)3H2, -C(=O)NR9R9, -NR9R9, -S(O)2NR9R9, - NR9S(O)2CF3, -C(=O)NR9S(O)2R9, -S(O)2NR9C(=O)OR9, -S(O)2NR9C(=O)NR9R9, -C(=O)NR9S(O)2CF3, -C(=O)R10, -NR9C(=O)H, -NR9C(=O)R10, -OC(=O)R10, -C(=NR14)NR9R9, -NHC(=NR14)NR14R14, -S(=O)R10, -S(O)2R10, =O, -NR9C(=O)OR8 i -NR9S(O2)R8, gdje alkil, alkenil, alkinil, aril, cikloalkil, cikloalkilalkil, heteroaril, heteroarilalkil, heterociklil i heterociklilalkil može svaki biti po izboru supstituiran s 0-5 R9a;R7, svaki put kada je prisutan, je nezavisno izabran iz grupe koja obuhvaća alkil, halogenalkil, aril, alkenil, alkinil, cikloalkil, cikloalkilalkil, heterociklil, halogen, - NH2, -CN, -NO2, -C(=O)OH, -C(=O)OR10, -OCF3, -OR10, -OH, -SH, -SR10, -S(O)3H, -P(O)3H2, -C(=O)NR9R9, -NR9R9, -S(O)2NR9R9, -NR9S(O)2CF3, -C(=O)NR9S(O)2R9, -S(O)2NR9C(=O)OR9, -S(O)2NR9C(=O)NR9R9, -C(=O)NR9S(O)2CF3, -C(=O)R10, -NR9C(=O)H, -NR9C(=O)R10, -OC(=O)R10, -C(=NR14)NR9R9,- NHC
Patent SI-1492773-T1 (SI)
Title: 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
Inventor: LOHRAY BRAJ BHUSHAN
IPC: A61K31/00
Filed: 2003-04-01
Abstract: We describe substituted benzenesulfoximine compounds having anti-inflammatory activity, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of inflammatory diseases.
Patent SI-1648933-T1 (SI)
Title: Long lasting insulin derivatives and methods thereof
Inventor: BRIDON DOMINIQUE P
IPC: A61K38/00
Filed: 2004-07-26
Abstract: The present invention relates to an insulin derivative comprising an insulin molecule and a reactive group for covalently bonding a blood component, wherein preferably the insulin molecule is human natural insulin molecule and the reactive group is coupled to an amino acid of the insulin molecule at a position selected from the positions Gly A1, Phe B1 and Lys B29.
Patent SI-1676278-T1 (SI)
Title: Playback device and method for providing functionality based on event information retrieved from a playlist
Inventor: KELLY DECLAN P
IPC: H04N5/85
Filed: 2004-10-07
Abstract: A playback device for retrieving a data stream having video data includes a java processor for processing a Java application; and a memory operably coupled to the java processor. The Java processor includes an input for receiving an event information associated with playback of a video section of the data stream. The event information is received from a playlist for the data stream and activates functionality provided by the Java application, the functionality being activated concurrently with the playback of the associated video section. The playlist includes a mark for controlling playback of the video section, the mark includes a presentation time. The event information is information indicating that the playback device has reached the mark presentation time during playback.
Patent SI-2070948-T1 (SI)
Title: Humanized Anti-CD4 antibody with immunosuppressive properties
Inventor: WIJDENES JOHN
IPC: C12N15/13
Filed: 2004-03-19
Abstract: Provided is a humanized anti-CD4 antibody which is capable of activating CD4 +  CD25 +  regulatory T cells, wherein the humanized anti-CD4 antibody comprises a sequence comprising the complementarity-determining regions (CDRs) of the mouse monoclonal anti-CD4 antibody B-F5, optionally with variations in the sequence that do not substantially affect the antibody specificity and/or affinity thereof.
Patent SI-2805728-T1 (SI)
Title: Novel anti-IL 13 antibodies and uses thereof
Inventor: FUNG SEK CHUNG MICHAEL
IPC: C07K16/00
Filed: 2004-12-23
Abstract: The present invention relates to ant-IL-13 antibodies that bind specifically and with high affinity to both glycosylated and non-glycosylated human IL13, does not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13). The invention also relates to the use of these antibodies in the treatment of IL13-mediated diseases, such as allergic disease, including asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and osteoporosis.
Patent SI-2425520-T1 (SI)
Title: Apparatus for winding and terminating dynamo electric machine cores
Inventor: PONZIO MASSIMO
IPC: H02K15/00
Filed: 2010-04-28
Abstract: A method for terminating and winding coils of a core (20) of a dynamo electric machine. The coils being formed from at least an electric wire (W) and the core (20) having a longitudinal axis (20′). The coils (19) are wound by relatively moving a wire dispenser (21) with respect to a core with relative motions of translation and rotation; at least a stretch of wire extends from the coil and the stretch of wire is provided with a portion (W4) for a termination connection to a termination structure (22) of the core (20) such as a tang. The method avoids waste cut wire in the apparatus. The core is provided with a groove (120) at an end to receive at least a wire in the path of the wire for the termination of the coils. The apparatus comprises a wire deflector positioned adjacent the end of the core, where the groove (120) is located, in order to intercept and align the wire with the groove (120). The apparatus can comprise a device for applying torques in two directions on a pulley wheel for feeding wire as a function of the position of the dispenser in the translation and the position of the core in the rotations.
Patent DE-3587030-T2 (DE)
Inventor: KEEN ALAN ROBERT DAIRY RES INS
IPC: A23C15/14
Filed: 1985-09-11
Granted: 1993-05-13
Abstract: Compounds at least one of which is a selected compound specifically cholesterol are removed from fats or oils specifically anhydrous milk fat by passing liquid fat or oil over an absorbent or adsorbent material specifically granulated active carbon.
Patent DE-3688506-T2 (DE)
Inventor: SASAKI YOSHINARI
IPC: G06F9/44
Filed: 1986-08-13
Granted: 1993-09-09
Abstract: In a computer system suitable for effecting a sequence control and a servo-control, programs are prepared by using three types of parallel processing instructions consisting of an open instruction, a close instruction and a pause instruction. The open instruction is issued from a first program ( alpha  ) for parallelly processing a second program ( beta ). The close instruction is issued from the first program ( alpha ) to terminate the first ( alpha ) or second program ( beta ). The pause instruction is issued from the first program ( alpha ) to stop execution of the first program ( alpha ) for a definite interval. With this system it is not necessary to use system languages as programming languages, but such languages as BASIC and FORTRAN can be used.
Patent DE-3750443-T2 (DE)
Inventor: ZAMA YOSHIYUKI
IPC: C07D417/12
Filed: 1987-06-30
Granted: 1995-04-20
Abstract: A cephalosporin compound having the formula: <CHEM> wherein R1 is a hydrogen atom, a halogen atom, a methoxy group, a substituted or unsubstituted vinyl group, or -CH2-A wherein A is a hydrogen atom, an azido group, an acyloxy group, a carbamoyloxy group, a substituted or unsubstituted heterocyclic group (wherein the hetrocyclic ring is a 5- or 6-membered heterocyclic ring having from l to 4 oxygen, nitrogen or sulfur atoms), or a substituted or unsubstituted heterocyclic thio group (wherein the heterocyclic ring is a monocyclic or bicyclic heterocyclic ring having from l to 5 oxygen, nitrogen or sulfur atoms), or a pharmaceutically acceptable salt thereof.
Patent DE-3878000-T2 (DE)
Inventor: HARMAN GARY E
IPC: A01N63/38
Filed: 1988-03-29
Granted: 1993-07-01
Abstract: Fused strains of Trichoderma spp described herein are useful as biocontrol agents to protect seeds, especially when used in conjunction with solid matrix priming or osmoconditioning.
Patent DE-3879529-T2 (DE)
Inventor: BAHR KARL E
IPC: B23K1/00
Filed: 1988-02-12
Granted: 1993-08-26
Abstract: An improved solder reflow system for mass joining with solder electrical and electronic components affixed on a circuit board is provided. The system employs a combination of IR heating, recirculating forced hot air heating, and focused forced hot air heating to achieve solder reflow at throughput speeds and soldering quality not heretofore achievable.
Patent DE-3880511-T2 (DE)
Inventor: HALLEWELL ROBERT A
IPC: C12N1/18
Filed: 1988-01-14
Granted: 1993-08-12
Abstract: Thermostable muteins of human Cu/Zn superoxide dismutase (hSOD) in which one or both of the free cysteine residues at positions 6 and lll are replaced with an uncharged amino acid. hSOD Ala6, hSOD Serlll, and hSOD Ala6 Serlll are specifically exemplified.
Patent DE-3882702-T2 (DE)
Inventor: CARLQVIST STIG
IPC: F16H21/18
Filed: 1988-01-28
Granted: 1994-02-10
Abstract: PCT No. PCT/SE88/00030 Sec. 371 Date Jun. 28, 1989 Sec. 102(e) Date Jun. 28, 1989 PCT Filed Jan. 28, 1988 PCT Pub. No. WO88/05878 PCT Pub. Date Aug. 11, 1988.A motion transmitting mechanism for heat engines, refrigerating machines and heat pumps which are hermetically sealed or provided with rotary shaft seals and have reciprocating pistons connected to the motion transmitting mechanism (11) by means of connecting rods (33, 34, 23, 24), is provided with two counterrotating crank systems which are centered along a single center line, whereby the lateral forces of the pistons counteract each other so as to be eliminated and allow the use of permanent grease-lubricated and sealed rolling bearings (22, 25, 26, 35, 36).